Switch theme
Sign up to access all valuation multiples
Vitro SAB de CV is a glass manufacturing company. The company is principally engaged in the production, processing, distribution, and marketing range of glassware. Its reportable segment includes Flat glass; Chemicals and Glass containers. Flat glass is used for the construction and automotive industries, carbonate, and sodium bicarbonate products. Its Glass containers are used in precision components, as well as machinery and molds for the glass industry. The company derives the maximum revenue from the Flat Glass segment. Geographically, it generates a majority of its revenue from the USA.
1909
14.8K+
Last FY Revenue $16.7M
Last FY EBITDA $10.9M
$217M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Vitro SAB de achieved revenue of $16.7M and an EBITDA of $10.9M.
Vitro SAB de expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Vitro SAB de valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $16.7M | XXX | XXX | XXX |
| Gross Profit | XXX | $8.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 49% | XXX | XXX | XXX |
| EBITDA | XXX | $10.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 65% | XXX | XXX | XXX |
| EBIT | XXX | $1.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | 12% | XXX | XXX | XXX |
| Net Profit | XXX | $6.9M | XXX | XXX | XXX |
| Net Margin | XXX | 42% | XXX | XXX | XXX |
| Net Debt | XXX | $4.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Vitro SAB de's stock price is MXN 5 (or $0).
Vitro SAB de has current market cap of MXN 2.5B (or $135M), and EV of MXN 4.0B (or $217M).
See Vitro SAB de trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $217M | $135M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Vitro SAB de has market cap of $135M and EV of $217M.
Vitro SAB de's trades at 13.0x EV/Revenue multiple, and 20.0x EV/EBITDA.
Equity research analysts estimate Vitro SAB de's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vitro SAB de's P/E ratio is not available.
See valuation multiples for Vitro SAB de and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $135M | XXX | $135M | XXX | XXX | XXX |
| EV (current) | $217M | XXX | $217M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 20.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 112.3x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 15.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVitro SAB de's revenue per employee in the last FY averaged $1K, while opex per employee averaged $0K for the same period.
Vitro SAB de's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vitro SAB de's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Vitro SAB de and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 65% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| James Hardie | XXX | XXX | XXX | XXX | XXX | XXX |
| MATHIOS REFRACTORY | XXX | XXX | XXX | XXX | XXX | XXX |
| Cementos Argos | XXX | XXX | XXX | XXX | XXX | XXX |
| Grupo Argos | XXX | XXX | XXX | XXX | XXX | XXX |
| Ambuja Cements | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vitro SAB de acquired XXX companies to date.
Last acquisition by Vitro SAB de was XXXXXXXX, XXXXX XXXXX XXXXXX . Vitro SAB de acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Vitro SAB de founded? | Vitro SAB de was founded in 1909. |
| Where is Vitro SAB de headquartered? | Vitro SAB de is headquartered in Mexico. |
| How many employees does Vitro SAB de have? | As of today, Vitro SAB de has 14.8K+ employees. |
| Is Vitro SAB de publicy listed? | Yes, Vitro SAB de is a public company listed on MEX. |
| What is the stock symbol of Vitro SAB de? | Vitro SAB de trades under VITROA ticker. |
| When did Vitro SAB de go public? | Vitro SAB de went public in 1976. |
| Who are competitors of Vitro SAB de? | Similar companies to Vitro SAB de include e.g. James Hardie, MATHIOS REFRACTORY, Cementos Argos, Grupo Argos. |
| What is the current market cap of Vitro SAB de? | Vitro SAB de's current market cap is $135M |
| Is Vitro SAB de profitable? | Yes, Vitro SAB de is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
